Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

Project cooperationUpdated on 19 August 2026

Expertise in Cancer Biology, Molecular Targets and Innovative Therapeutic Approaches

Lab Head at Institute of Biochemistry named after H Buniatian

Yerevan, Armenia

About

What we offer:

The H. Buniatian Institute of Biochemistry, NAS RA, offers expertise in molecular biochemistry, pharmacology, cancer-related molecular mechanisms, and translational biomedical research. Our research includes investigation of PRPS-1 as a potential molecular target in glioma and development of innovative approaches for cancer diagnosis and therapy.

We also have expertise in bioactive compounds, protein- and peptide-based approaches, oxidative stress, molecular mechanisms of cell proliferation, and experimental evaluation of therapeutic strategies.

What we are looking for:

We are seeking European research institutions, universities, hospitals, biotechnology and pharmaceutical companies interested in collaborative cancer research, particularly in molecular targets, glioma/glioblastoma, biomarker discovery, innovative therapeutics, and translational research.

Potential role:

Research partner contributing biochemical, pharmacological and preclinical expertise to Horizon Europe consortia and collaborative projects.

Type

  • Partner seeks Consortium/Coordinator

Organisation

Similar opportunities